Benazepril Hydrochloride
- Product NDC
- 42291-162
- 11-digit product format
- 422910162
- Labeler code
- 42291
- Product ID
- 42291-162_f1602147-8ad7-de48-e053-2995a90a735c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Benazepril Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA076820
- Marketing category
- ANDA
- Marketing start
- 2009-07-29
- Marketing end
- 0000-00-00
- Substance
- BENAZEPRIL HYDROCHLORIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-162-01 | 42291016201 | 100 TABLET in 1 BOTTLE (42291-162-01) | 100 tablet | 2016-09-07 | 0000-00-00 | No | No | Current |
| 42291-162-50 | 42291016250 | 500 TABLET in 1 BOTTLE (42291-162-50) | 500 tablet | 2009-07-29 | 0000-00-00 | No | No | Current |